SHERRY KENT: Open Payments
NPI 1205812799 · BEAUFORT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 21 payments from 11 companies in 2025. Trend: 2023 $970 · 2024 $1,029 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $208 |
| Novo Nordisk Inc | 3 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Astellas Pharma US Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, MOUNJARO, Veozah, TRELEGY ELLIPTA, REXULTI, VRAYLAR, Wegovy.
Industry payments across NC — which companies pay providers there.
